196 related articles for article (PubMed ID: 10087261)
21. Vaults: a ribonucleoprotein particle involved in drug resistance?
Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of major vault protein during the life cycle of the human parasite Schistosoma mansoni.
Reis EV; Pereira RV; Gomes M; Jannotti-Passos LK; Baba EH; Coelho PM; Mattos AC; Couto FF; Castro-Borges W; Guerra-Sá R
Parasitol Int; 2014 Feb; 63(1):120-6. PubMed ID: 24148287
[TBL] [Abstract][Full Text] [Related]
23. The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior.
Poderycki MJ; Kickhoefer VA; Kaddis CS; Raval-Fernandes S; Johansson E; Zink JI; Loo JA; Rome LH
Biochemistry; 2006 Oct; 45(39):12184-93. PubMed ID: 17002318
[TBL] [Abstract][Full Text] [Related]
24. Receptor subtype-induced targeting and subtype-specific internalization of human alpha(2)-adrenoceptors in PC12 cells.
Olli-Lähdesmäki T; Kallio J; Scheinin M
J Neurosci; 1999 Nov; 19(21):9281-8. PubMed ID: 10531432
[TBL] [Abstract][Full Text] [Related]
25. Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.
Yang J; Kickhoefer VA; Ng BC; Gopal A; Bentolila LA; John S; Tolbert SH; Rome LH
ACS Nano; 2010 Dec; 4(12):7229-40. PubMed ID: 21121616
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling.
Kim E; Lee S; Mian MF; Yun SU; Song M; Yi KS; Ryu SH; Suh PG
FEBS J; 2006 Feb; 273(4):793-804. PubMed ID: 16441665
[TBL] [Abstract][Full Text] [Related]
27. Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.
Lötsch D; Steiner E; Holzmann K; Spiegl-Kreinecker S; Pirker C; Hlavaty J; Petznek H; Hegedus B; Garay T; Mohr T; Sommergruber W; Grusch M; Berger W
Oncotarget; 2013 Nov; 4(11):1904-18. PubMed ID: 24243798
[TBL] [Abstract][Full Text] [Related]
28. Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies.
Yang J; Nagasawa DT; Spasic M; Amolis M; Choy W; Garcia HM; Prins RM; Liau LM; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):451-8. PubMed ID: 22748657
[TBL] [Abstract][Full Text] [Related]
29. Solution Structures of Engineered Vault Particles.
Ding K; Zhang X; Mrazek J; Kickhoefer VA; Lai M; Ng HL; Yang OO; Rome LH; Zhou ZH
Structure; 2018 Apr; 26(4):619-626.e3. PubMed ID: 29551289
[TBL] [Abstract][Full Text] [Related]
30. MVP and vaults: a role in the radiation response.
Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
[TBL] [Abstract][Full Text] [Related]
31. The La RNA-binding protein interacts with the vault RNA and is a vault-associated protein.
Kickhoefer VA; Poderycki MJ; Chan EK; Rome LH
J Biol Chem; 2002 Oct; 277(43):41282-6. PubMed ID: 12196535
[TBL] [Abstract][Full Text] [Related]
32. Structural studies of large nucleoprotein particles, vaults.
Tanaka H; Tsukihara T
Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(8):416-33. PubMed ID: 23060231
[TBL] [Abstract][Full Text] [Related]
33. Solution structure of a two-repeat fragment of major vault protein.
Kozlov G; Vavelyuk O; Minailiuc O; Banville D; Gehring K; Ekiel I
J Mol Biol; 2006 Feb; 356(2):444-52. PubMed ID: 16373071
[TBL] [Abstract][Full Text] [Related]
34. Draft crystal structure of the vault shell at 9-A resolution.
Anderson DH; Kickhoefer VA; Sievers SA; Rome LH; Eisenberg D
PLoS Biol; 2007 Nov; 5(11):e318. PubMed ID: 18044992
[TBL] [Abstract][Full Text] [Related]
35. Vault nanocapsule dissociation into halves triggered at low pH.
Goldsmith LE; Yu M; Rome LH; Monbouquette HG
Biochemistry; 2007 Mar; 46(10):2865-75. PubMed ID: 17302392
[TBL] [Abstract][Full Text] [Related]
36. Structural stability of vault particles.
Esfandiary R; Kickhoefer VA; Rome LH; Joshi SB; Middaugh CR
J Pharm Sci; 2009 Apr; 98(4):1376-86. PubMed ID: 18683860
[TBL] [Abstract][Full Text] [Related]
37. Vault Nanoparticles: Chemical Modifications for Imaging and Enhanced Delivery.
Benner NL; Zang X; Buehler DC; Kickhoefer VA; Rome ME; Rome LH; Wender PA
ACS Nano; 2017 Jan; 11(1):872-881. PubMed ID: 28029784
[TBL] [Abstract][Full Text] [Related]
38. Direct visualization of vaults within intact cells by electron cryo-tomography.
Woodward CL; Mendonça LM; Jensen GJ
Cell Mol Life Sci; 2015 Sep; 72(17):3401-9. PubMed ID: 25864047
[TBL] [Abstract][Full Text] [Related]
39. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon.
Liu S; Hao Q; Peng N; Yue X; Wang Y; Chen Y; Wu J; Zhu Y
Hepatology; 2012 Jul; 56(1):57-66. PubMed ID: 22318991
[TBL] [Abstract][Full Text] [Related]
40. Multiple human vault RNAs. Expression and association with the vault complex.
van Zon A; Mossink MH; Schoester M; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
J Biol Chem; 2001 Oct; 276(40):37715-21. PubMed ID: 11479319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
